Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Affiliations

• ¹ Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam and LYMMCARE, Amsterdam, The Netherlands.
• ² Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.
• ³ Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
• ⁴ Department of Hematology, Hospital Universitario de La Princesa, Madrid, Spain.
• ⁵ Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
• ⁶ Department of Hematology, Hospital Clínic, Barcelona, Spain.
• ⁷ Department of Hematology, Vall d'Hebron University Hospital, Vall d'Hebron, Barcelona, Spain.
• ⁸ Department of Hematology, Institute of Health Research Gregorio Marañon, Hospital G. Universitario Gregorio Marañon, Madrid, Spain.
• ⁹ Department of Hematology, Hospital Universitario de Salamanca, IBSAL, Salamanca, Spain.
• ¹⁰ Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Lyon, Pierre-Bénite, France.
• ¹¹ Department of Hematology, Assistance Publique Hôpitaux de Paris-Hopital Saint-Louis, Paris, France.
• ¹² Department of Stem cell Transplantation,Princess Maxima Centre for Paediatric Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands.
• ¹³ Department of Hematology, Erasmus MC Cancer Center, Rotterdam, The Netherlands.
• ¹⁴ Deptartment of Hematology, University Hospital Gasthuisberg, Leuven, Belgium.
• ¹⁵ Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
• ¹⁶ Department of Haematology, The Royal Marsden Hospital, London, UK.
• ¹⁷ Adult HSCT Unit, Northern Centre for Bone Marrow Transplantation, Newcastle Tyne, UK.
• ¹⁸ BMT Unit, Inst. Português de Oncologia do Porto, Porto, Portugal.
• ¹⁹ Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
• ²⁰ Department of Hematology, Hospital Univ. 12 de Octubre, CNIO, Complutense University, Madrid, Spain.
• ²¹ Clinical Haematology Department, Manchester Royal Infirmary, Manchester, UK.
• ²² Clinical Hematology Department, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Josep Carreras Research Institute, Barcelona, Spain.
• ²³ Chaim Sheba Medical Center, Tel Aviv University, Tel HaShomer, Tel Aviv-Yafo, Israel.
• ²⁴ Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czechia.
• ²⁵ Department of Haematological Medicine, Kings College Hospital, London, UK.
• ²⁶ Adult Leukaemia and Bone Marrow Transplant Unit, Christie NHS Trust Hospital, University of Manchester, Manchester, UK.
• ²⁷ Hematology and BMT Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
• ²⁸ Dept. of Medical Statistics & Bioinformatics, EBMT Data Office, Leiden, The Netherlands.
• ²⁹ Department of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany.
• ³⁰ Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge and Karolinska Comprehensive Cancer Center, Stockholm, Sweden. [email protected].
• ³¹ Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. [email protected].
• ³² Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden. [email protected].